BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hu X, Chen W. Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma. World J Clin Cases 2021; 9(19): 4998-5006 [PMID: 34307550 DOI: 10.12998/wjcc.v9.i19.4998]
URL: https://www.wjgnet.com/1948-0210/full/v9/i19/4998.htm
Number Citing Articles
1
Chaithanya Ganji, Batoul Farran. Current clinical trials for epigenetic targets and therapeutic inhibitors for pancreatic cancer therapyDrug Discovery Today 2022; 27(5): 1404 doi: 10.1016/j.drudis.2021.12.013
2
Ziad Chebaro, Rola Abdallah, Adnan Badran, Kamar Hamade, Akram Hijazi, Marc Maresca, Joelle Edward Mesmar, Elias Baydoun. Study of the antioxidant and anti-pancreatic cancer activities of Anchusa strigosa aqueous extracts obtained by maceration and ultrasonic extraction techniquesFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1201969
3
Antonella Farina, Sara Tartaglione, Adele Preziosi, Patrizia Mancini, Antonio Angeloni, Emanuela Anastasi. PANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanisms Leading to Protein Release in PDACInternational Journal of Molecular Sciences 2024; 25(6): 3498 doi: 10.3390/ijms25063498
4
Praveen Bhoopathi, Padmanabhan Mannangatti, Swadesh K. Das, Paul B. Fisher, Luni Emdad. Pancreatic Cancer: Basic Mechanisms and TherapiesAdvances in Cancer Research 2023; 159: 285 doi: 10.1016/bs.acr.2023.02.010
5
Aiste Gulla, Urte Andriusaityte, Gabrielius Zdanys, Elena Babonaite, Kestutis Strupas, Helena Kelly. The Impact of Epithelial–Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized TherapyMedicina 2022; 58(4): 467 doi: 10.3390/medicina58040467
6
Natalia Kluz, Leszek Kraj, Paulina Chmiel, Adam M. Przybyłkowski, Lucjan Wyrwicz, Rafał Stec, Łukasz Szymański. Correlation Between Antihypertensive Drugs and Survival Among Patients with Pancreatic Ductal AdenocarcinomaCancers 2024; 16(23): 3945 doi: 10.3390/cancers16233945
7
Min-Woo Nam, Hong Kyu Lee, Cho-Won Kim, Youngdong Choi, Dohee Ahn, Ryeo-Eun Go, Kyung-Chul Choi. Effects of CCN6 overexpression on the cell motility and activation of p38/bone morphogenetic protein signaling pathways in pancreatic cancer cellsBiomedicine & Pharmacotherapy 2023; 163: 114780 doi: 10.1016/j.biopha.2023.114780
8
Umbhorn Ungkulpasvich, Hideyuki Hatakeyama, Takaaki Hirotsu, Eric di Luccio. Pancreatic Cancer and Detection MethodsBiomedicines 2023; 11(9): 2557 doi: 10.3390/biomedicines11092557
9
Mona Tangsiri, Ali Hheidari, Mahsa Liaghat, Mahtab Razlansari, Narges Ebrahimi, Abdullatif Akbari, Seyed Mostafa Noorbakhsh Varnosfaderani, Fahimeh Maleki-Sheikhabadi, Ali Norouzi, Maryam Bakhtiyari, Hamidreza Zalpoor, Mohsen Nabi-Afjadi, Abbas Rahdar. Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT)Biomedicine & Pharmacotherapy 2024; 170: 115973 doi: 10.1016/j.biopha.2023.115973
10
Antonella Farina, Valentina Viggiani, Francesca Cortese, Marta Moretti, Sara Tartaglione, Antonio Angeloni, Emanuela Anastasi. Combined PIVKA II and Vimentin-Guided EMT Tracking in Pancreatic Adenocarcinoma Combined Biomarker-Guided EMT Tracking in PDACCancers 2024; 16(13): 2362 doi: 10.3390/cancers16132362